Considerations To Know About GM-CSF/CSF2 Protein
123). It's noteworthy that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This suggests that GLS2 could confer resistance to GLS1-particular inhibitors, including the allosteric inhibitor BPTES or CB-839, and this resistance might be hypothetically averted by the us